← Leaderboards
Quin Shi
Glycan Therapeutics Corporation
$299,447
Attributed
$299,447
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$299,447 · 1
By mechanism
N43$299,447 · 1
Top collaborators
No co-investigators on record.
Most similar at Glycan Therapeutics Corporation
Same institution · by research overlap
- Vijayakanth Pagadala$12,153,122
- Guowei Su$5,499,306
- Zhangjie Wang$4,365,125
Others in their field
Top investigators on “2-Cyclopentyl-5-(5-Isoquinolylsulfonyl)-6-Nitro-1h-Benzo(D)Imidazole”
- Doug Livingston · Compound Focus, Inc.$12,277,761
- Philip Lograsso · Scripps Research Institute, The$7,700,546
- Barry Coller · Rockefeller University$3,374,538
- Aleem Gangjee · Wayne State University$2,698,328
- David S Ludwig · Children'S Hospital Boston$2,666,502
- John A Secrist · Southern Research Institute$2,251,169
Research focus
2-Cyclopentyl-5-(5-Isoquinolylsulfonyl)-6-Nitro-1h-Benzo(D)ImidazoleAffinityAnionsAntithrombinsBinding (Molecular Function)Chemical SynthesisCollectionCompound 17ContractorContractsCost EffectiveDisaccharidesElementsExhibitsGlucosamineGlucosamine SulfateGlucuronic AcidsGood Laboratory PracticeHeparinHeparitin SulfateHigh Pressure Liquid ChromatographyIduronic AcidInnovationInorganic Sulfates